Stock Rich List
#531 on the corporate holders of 809 holders

New Enterprise Associates 14, L.P.

10% owner at Enliven Therapeutics.

$153M
in disclosed stock, +$5.0M (+3.39%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
531st of 809
Companies held
1
Largest holding
ELVN, 100.0% of total
Latest SEC filing
Jan 25, 2022

What the $153M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Enliven Therapeutics ELVN
Common Stock
Directly3,305,601$46.41$153M100.0%Form 4, Jan 25, 2022

Share counts are the amounts New Enterprise Associates 14, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
528Boxer Capital Management, LLC
Insider, Tango Therapeutics
$154M+$5.6M (+3.75%)
529Yorktown Energy Partners IX, L.P.
10% owner, Riley Exploration Permian
$154M−$637K (−0.41%)
530Third Rock Ventures V, L.P.
Director, Rapport Therapeutics
$154M+$1.2M (+0.81%)
531New Enterprise Associates 14, L.P.
10% owner, Enliven Therapeutics
$153M+$5.0M (+3.39%)
532Mpm Asset Management LLC
10% owner, Aktis Oncology
$153M+$2.4M (+1.58%)
533RC IV Cayman ICW Equity LLC
Insider, Driven Brands Holdings
$152M−$2.1M (−1.37%)
534Honeywell International INC
10% owner, Quantinuum
$152M−$567K (−0.37%)

Other Enliven Therapeutics insiders

All ELVN insiders

Questions

How much stock does New Enterprise Associates 14, L.P. own?

New Enterprise Associates 14, L.P. holds $153,412,942 in listed stock based on SEC filings and current prices, mostly Enliven Therapeutics (ELVN). That ranks 531st on the Stock Rich List.

Is this New Enterprise Associates 14, L.P.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with SEC filer 1235112, Scott D. Sandell, SEC filer 1277631, SEC filer 1559807, SEC filer 1559827.